Pleth Variability Index to predict low blood pressure during maintenance hemodialysis

The Value of Pleth Variability Index in Predicting Hypotension During Maintenance Hemodialysis: A Prospective Observational Multicenter Study

Observational First Affiliated Hospital of Wannan Medical College · NCT07022847

This will test whether a simple pulse-oximeter reading (PVI) can help predict which adults on routine hemodialysis will develop low blood pressure so clinicians can act earlier.

Quick facts

Study typeObservational
Enrollment200 (estimated)
Ages18 Years to 80 Years
SexAll
SponsorFirst Affiliated Hospital of Wannan Medical College Academic / other
Locations1 site (Wuhu, Anhui)
Trial IDNCT07022847 on ClinicalTrials.gov

What this trial studies

This observational study will record Pleth Variability Index (PVI) values noninvasively from a pulse oximeter during regular maintenance hemodialysis sessions in adults. Participants are adults aged 18–80 who have been on thrice- or regularly scheduled hemodialysis for more than three months, with exclusions for severe arrhythmias, major peripheral vascular disease, or local conditions preventing accurate PVI measurement. Investigators will compare PVI trends and pre-dialysis or intra-dialytic clinical data with episodes of intradialytic hypotension to determine predictive relationships. The goal is to determine whether PVI readings can reliably flag patients at higher short-term risk of low blood pressure during dialysis.

Who should consider this trial

Good fit: Adults aged 18 to 80 who have been receiving maintenance hemodialysis for more than three months and who can give informed consent and cooperate with monitoring are ideal candidates.

Not a fit: Patients with severe cardiac arrhythmias, significant peripheral vascular disease or local edema that prevents accurate PVI measurement, pregnant or breastfeeding women, or those allergic to dialysis circuit materials may not receive benefit from PVI monitoring.

Why it matters

Potential benefit: If successful, noninvasive PVI monitoring could give clinicians an early warning of patients at risk for intradialytic hypotension, allowing preventive steps to reduce symptoms and complications.

How similar studies have performed: PVI has shown usefulness for predicting fluid responsiveness in surgical and critical care settings, but its application to predicting intradialytic hypotension is relatively novel with limited and mixed observational evidence.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 80 years.
* Diagnosis of end-stage renal disease and undergoing maintenance hemodialysis for more than 3 months.
* Able and willing to provide informed consent and comply with study procedures.

Exclusion Criteria:

* Severe cardiac arrhythmias or significant peripheral vascular disease that may interfere with PVI measurements.
* Local edema, skin lesions, or other conditions that prevent accurate PVI monitoring.
* History of hemodynamic instability unrelated to dialysis.
* Pregnant or breastfeeding women.
* Known allergy or contraindication to materials used in the hemodialysis circuit.
* Unable to cooperate with study procedures.
* Participation in another interventional clinical study within the past 30 days.

Where this trial is running

Wuhu, Anhui

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hypotension and ShockHemodialysisEnd-Stage Renal Disease Requiring HaemodialysisIntradialytic HypotensionPleth Variability IndexBlood Pressure MonitoringEnd-Stage Renal DiseaseNon-invasive Monitoring
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.